Session VI: Presentation of Selected Non-Colorectal Cancer Abstracts - Esophageal and Stomach Cancers
O-5: Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG
